KTX-2001

N/A

Report date: 2025/08/07 20:00:08
NME

Base Information

Drug NameKTX-2001
Drug Alias NameKTX-2001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone-lysine N-methyltransferase NSD2 inhibitors
TargetsHistone-lysine N-methyltransferase NSD2
Therapy Area/IndicationsProstatic Neoplasms, Castration-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesK36 Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesK36 Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms, Castration-Resistant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A